- Home
- ADCT vs CAL Comparison
ADCT vs CAL Comparison
Compare ADCT & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- CAL
- Stock Information
- Founded
- ADCT 2011
- CAL 1878
- Country
- ADCT Switzerland
- CAL United States
- Employees
- ADCT N/A
- CAL N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- ADCT Health Care
- CAL Consumer Discretionary
- Exchange
- ADCT Nasdaq
- CAL Nasdaq
- Market Cap
- ADCT 454.5M
- CAL 382.4M
- IPO Year
- ADCT 2020
- CAL N/A
- Fundamental
- Price
- ADCT $4.40
- CAL $11.76
- Analyst Decision
- ADCT Strong Buy
- CAL Hold
- Analyst Count
- ADCT 6
- CAL 1
- Target Price
- ADCT $7.60
- CAL $14.00
- AVG Volume (30 Days)
- ADCT 759.6K
- CAL 1.5M
- Earning Date
- ADCT 11-10-2025
- CAL 12-09-2025
- Dividend Yield
- ADCT N/A
- CAL 2.37%
- EPS Growth
- ADCT N/A
- CAL N/A
- EPS
- ADCT N/A
- CAL 1.76
- Revenue
- ADCT $75,209,000.00
- CAL $2,652,908,000.00
- Revenue This Year
- ADCT $11.78
- CAL $1.74
- Revenue Next Year
- ADCT $4.83
- CAL $5.85
- P/E Ratio
- ADCT N/A
- CAL $6.70
- Revenue Growth
- ADCT 6.35
- CAL N/A
- 52 Week Low
- ADCT $1.05
- CAL $9.54
- 52 Week High
- ADCT $4.80
- CAL $33.22
- Technical
- Relative Strength Index (RSI)
- ADCT 58.45
- CAL 55.18
- Support Level
- ADCT $3.95
- CAL $9.54
- Resistance Level
- ADCT $4.29
- CAL $10.70
- Average True Range (ATR)
- ADCT 0.28
- CAL 0.55
- MACD
- ADCT 0.03
- CAL 0.21
- Stochastic Oscillator
- ADCT 89.02
- CAL 94.87
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.